← FDA Drug Approvals (Drugs@FDA)

OXANDROLONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAR PHARM · Approved 2007-06-22

Drug application

FDA Application #

ANDA077827

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXANDROLONE

Generic name

Oxandrolone

Active ingredients

OXANDROLONE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

PAR PHARM

First approval

2007-06-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown